---
schema_version: "secwatch.filing_event.v1"
accession: "0001799191-23-000029"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2023-08-09T23:59:59+00:00"
generated_at: "2026-06-11T23:01:42.871951+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# TOI Q2 revenue up 32% to $80M, net loss widens to $16.9M, reaffirms FY 2023 guidance

## Summary
- Revenue of $80M (+32% YoY); gross profit $15M (+36%); gross margin 18.8% vs 18.3%.
- Net loss of $16.9M vs $5.5M loss in prior year; EPS $(0.19) vs $(0.06).
- Adjusted EBITDA $(6.9)M, flat YoY; cash & investments $98M as of June 30, 2023.
- Acquired Southland Radiation Oncology Network; patient visits up 14%, oral drugs dispensed up 38% YoY.
- Reaffirmed full-year 2023 guidance; management cites strong topline growth and momentum.

## SEC filing metadata
- accession: 0001799191-23-000029
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2023-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000029/0001799191-23-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000029/toi-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001799191-23-000029
- JSON: https://secwatch.observer/filing/0001799191-23-000029.json
- Plain text: https://secwatch.observer/filing/0001799191-23-000029.txt

## Key facts
- Earnings Releases
  Oncology Institute, Inc. updated its three months ended June 30, 2023 guidance (reaffirmed).
  - Period: three months ended June 30, 2023
  - Guidance: reaffirmed
  - Result: reported results
  source text: On August 8, 2023, The Oncology Institute, Inc. (the "Company") issued a press release announcing its financial results for the three months ended June 30, 2023 and certain other financial information.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000029/0001799191-23-000029-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.